Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Syndax Pharmaceuticals, Inc. SNDX

Set alert

Price alert · SNDX

All alert types
14.28 USD +1.18 +8.97%

As of Nov 3, 1:55 PM ET

Bid
14.27 × 1
Ask
14.28 × 5
13.07 Day range 14.49
12.80 52-week range 25.59
YTD
-32.06%
1 year
+3.74%
Open
13.08
Prev close
13.10
Mkt cap
1.27B
Vol
2.99M
Avg vol
1.99M
EPS
-2.37
P/E
0.00
Div yield
0.00%
More statistics
Low
13.07
High
14.49
Forward P/E
-17.89
Beta
0.45
Short ratio
8.03
Inst. own
126.78%
Dividend
0.00
Ex-div date
Earnings
Feb 25, 2027
50-d avg
17.18
200-d avg
20.23
1y target
37.27

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 4, 2026Earnings: -0.55; estimate -0.44767; surprise -22.86%
  • Aug 5, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Aug 11, 2026Rating: JP Morgan · Overweight → Overweight
  • Aug 21, 2026Rating: UBS · Buy → Buy
  • Oct 13, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Nov 2, 2026Earnings: -0.55; estimate -0.4928; surprise -11.61%
Signals (10)
NameDateAgo
MACD: Buy SignalOct 28, 20266 days ago
RSI: OversoldOct 13, 20263 weeks ago
MACD: Sell SignalOct 7, 20263 weeks ago
MACD: Buy SignalSep 29, 20261 month ago
MACD: Sell SignalSep 10, 20261 month ago
SMA: BearishSep 9, 20261 month ago
SMA: BullishSep 1, 20262 months ago
SMA: BearishAug 20, 20262 months ago
SMA: BullishAug 19, 20262 months ago
MACD: Buy SignalAug 18, 20262 months ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 37.27 +161.1% upside
Target (low)
23.00
Target (mean)
37.27
Target (high)
57.00
Ratings (0m) 12 12 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy10
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 12
  • 1 month ago 12
  • 2 months ago 12

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

SNDX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.48378-0.58 – -0.375-0.70+30.9%81.81M+78.3%11
Next quarter-0.45558-0.60127 – -0.27-0.78+41.6%96.00M+39.7%11
Current year-1.95-2.25 – -1.60-3.29+40.7%314.09M+82.2%11
Next year-0.73205-1.96 – 0.39865-1.95+62.5%459.25M+46.2%11

Upgrades and downgrades

The latest rating changes

SNDX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 13, 2026HC Wainwright & Co.ReiteratedBuyBuy
Aug 21, 2026UBSMaintainedBuyBuy
Aug 11, 2026JP MorganMaintainedOverweightOverweight
Aug 5, 2026HC Wainwright & Co.MaintainedBuyBuy
Jul 15, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jun 12, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 22, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 13, 2026UBSMaintainedBuyBuy
May 1, 2026BarclaysMaintainedOverweightOverweight
Apr 1, 2026Goldman SachsMaintainedBuyBuy
Mar 31, 2026MizuhoMaintainedOutperformOutperform
Mar 9, 2026JP MorganMaintainedOverweightOverweight
Mar 2, 2026CitigroupMaintainedBuyBuy
Dec 9, 2025BTIGReiteratedBuyBuy
Nov 24, 2025BarclaysMaintainedOverweightOverweight
Nov 12, 2025JP MorganMaintainedOverweightOverweight
Nov 4, 2025UBSMaintainedBuyBuy
Nov 4, 2025BarclaysMaintainedOverweightOverweight
Oct 27, 2025HC Wainwright & Co.ReiteratedBuyBuy
Oct 27, 2025BTIGReiteratedBuyBuy
Sep 19, 2025BTIGReiteratedBuyBuy
Sep 5, 2025Goldman SachsMaintainedBuyBuy
Sep 4, 2025GuggenheimInitiated—Buy
Aug 5, 2025CitigroupMaintainedBuyBuy
Aug 5, 2025BTIGMaintainedBuyBuy
Jul 15, 2025UBSMaintainedBuyBuy
Jul 10, 2025Goldman SachsInitiated—Buy
May 6, 2025ScotiabankMaintainedSector PerformSector Perform
May 6, 2025GuggenheimReiteratedBuyBuy
Mar 20, 2025JP MorganMaintainedOverweightOverweight